Clinical Trials for Recurrent Myeloproliferative Neoplasm

Find clinical trials for recurrent myeloproliferative neoplasm. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

NCT ID: NCT06523556

This clinical trial is looking at a new treatment option for patients with certain serious blood cancers, including advanced phase myeloproliferative neoplasms (MPN), which are conditions where the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

NCT ID: NCT04493138

This clinical trial is investigating a combination of two medications, azacitidine and quizartinib, to see how well they work in treating patients with certain blood disorders called myelodysplasti...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions